The prevalence of atrophic gastritis and intestinal metaplasia according to gender, age and Helicobacter pylori infection in a rural population

Journal of Preventive Medicine and Public Health

Volumn 41, Issue 6, 2008, Pages 373-379

  Kim, Hyun Ja ^a   Choi, Bo Youl ^a   Byun, Tae Joon ^b   Eun, Chang Soo ^b   Song, Kyu Sang ^c   Kim, Yong Sung ^d   Han, Dong Soo ^a  

^a Department of Preventive Medicine Internal Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Chungnam National University   (South Korea)

^d Medical Genomics Research Center   (South Korea)

Author keywords

Atrophic gastritis; Helicobacter pylori; Korea; Metaplasia; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ATROPHIC GASTRITIS; CHI SQUARE DISTRIBUTION; DEMOGRAPHY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; METAPLASIA; MIDDLE AGED; PATHOLOGY; RURAL POPULATION; SEX DIFFERENCE; SMALL INTESTINE; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DEMOGRAPHY; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINE, SMALL; MALE; METAPLASIA; MIDDLE AGED; RURAL POPULATION; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 58949086096     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2008.41.6.373     Document Type: Article

References (38)

1. Korea National Statistical Office. Annual Report on the Cause of Death Statistics in 2006. Korea National Statistical Office: Daejeon, 2007.
2. Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, et al. Cancer incidence in Korea. Cancer Res Treat 2002;34(6):405-408.
3. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52(24):6735-6740.
5. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996;20(10):1161- 1181.
6. Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003;36(5 Suppl):S37-S43.
7. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: A systems approach. Nat Biotechnol 2006;24(8):905-908.
8. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, et al. Longterm sequelae of Helicobacter pylori gastritis. Lancet 1995;345(8964):1525-1528.
9. Zhang L, Blot WJ, You WC, Chang YS, Kneller RW, Jin ML, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 1996;5(8):627-630.
10. Ohkuma K, Okada M, Murayama H, Seo M, Maeda K, Kanda M, et al. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2000;15(10):1105-1112.
11. Asaka M, Sugiyama T, Nobuta A, Kato M, Takeda H, Graham DY. Atrophic gastritis and intestinal metaplasia in Japan: Results of a large multicenter study. Helicobacter 2001;6(4):294-299.
12. Korean H. pylori Study Group. Diagnosis and treatment of Helicobacter pylori infection in Korea. Korean J Gastroenterol 1998;32(3):275-289. (Korean)
13. International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter Pylori. Geneva: WHO; 1994: p. 177-240.
14. Coma Del Corral MJ, Pardo-Mindan FJ, Razquin S, Ojeda C. Risk of cancer in patients with gastric dysplasia. Follow-up study of 67 patients. Cancer 1990;65(9):2078-2085.
15. Inoue M, Tajima K, Matsuura A, Suzuki T, Nakamura T, Ohashi K, et al. Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: A 10-year prospective cohort study in Japan. Cancer Lett 2000;161(1):105-112.
16. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109(1):138-143.
17. De Vries AC, Van Grieken NC, Looman CW, Casparie MK, De Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: A nationwide cohort study in the Netherlands. Gastroenterology 2008;134(4):945-952.
18. Borch K, Jonsson KA, Petersson F, Redeen S, Mardh S, Franzen LE. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: Relations to symptomatology and life-style. Dig Dis Sci 2000;45(7):1322-1329.
19. You WC, Zhang L, Gail MH, Li JY, Chang YS, Blot WJ, et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998;27(6):945-948.
20. Namekata T, Miki K, Kimmey M, Fritsche T, Hughes D, Moore D, et al. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle. Am J Epidemiol 2000;151(8):820-830.
21. Dunn JE. Cancer epidemiology in populations of the United States-with emphasis on Hawaii and California- and Japan. Cancer Res 1975;35(11 Pt. 2):3240-3245.
22. Kim JH, Kim HY, Kim NY, Kim SW, Kim JG, Kim JJ, et al. Seroepidemiological study of Helicobacter pylori infection in asymptomatic people in South Korea. J Gastroenterol Hepatol 2001;16(9):969-975.
23. Yim JY, Kim N, Choi SH, Kim YS, Cho KR, Kim SS, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12(4):333-340.
24. Choi KH, Lee SH, Park YH. Prevalence of Helicobacter pylori infection among Korean adults in Pusan. Korean J Gastroenterol 1996;28(6):758-763. (Korean)
25. Song JB, Lee SH, Shin YM, Choi KH, Lee SD, Park YH. Seroprevalence of Helicobacter pylori infection in patients without gastric symptoms. Korean J Gastroenterol 1997;29(2):310-316. (Korean)
26. Kim N. Epidemiology and transmission route of Helicobacter pylori infection. Korean J Gastroenterol 2005;46(3):153-158. (Korean)
27. Replogle ML, Kasumi W, Ishikawa KB, Yang SF, Juji T, Miki K, et al. Increased risk of Helicobacter pylori associated with birth in wartime and post-war Japan. Int J Epidemiol 1996;25(1):210-214.
28. Farinati F, Valiante F, Germana B, Della Libera G, Baffa R, Rugge M, et al. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer. Eur J Cancer Prev 1993;2(4):321-326.
29. Asaka M, Kato M, Kudo M, Katagiri M, Nishikawa K, Koshiyama H, et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: Studies in asymptomatic Japanese adults. Helicobacter 1996;1(1):52-56.
30. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a highrisk region of China: A randomized controlled trial. JAMA 2004;291(2):187-194.
31. Lee Y, Jeon YC, Koo TY, Cho HS, Byun TJ, Kim TY, et al. Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication. Korean J Gastroenterol 2007;50(5):299-305. (Korean)
32. Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Perez-Perez GI, Peek RM Jr. Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 2008;88(3):328-336.
33. Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16(11):1923-1932.
34. Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, et al. Helicobacter pylori infection and development of gastric cancer in Korea: Longterm follow-up. J Clin Gastroenterol 2008;42(5):448-454.
35. Miwa H, Go MF, Sato N. H. pylori and gastric cancer: The Asian enigma. Am J Gastroenterol 2002;97(5):1106-1112.
36. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000;92(23):1881-1888.
37. Russo A, Maconi G, Spinelli P, Felice GD, Eboli M, Andreola S, et al. Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects. Am J Gastroenterol 2001;96(5):1402-1408.
38. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001;48(6):743-747.